In vitro cytotoxic effect of a chitin-like polysaccharide produced by Mortierella alpina on adrenocortical carcinoma cells H295R, and its use as mitotane adjuvant

被引:0
作者
Luis Daniel Goyzueta Mamani
Júlio Cesar de Carvalho
Sandro J. R. Bonatto
Valcineide A. O. Tanobe
Carlos Ricardo Soccol
机构
[1] Federal University of Paraná,Department of Bioprocess Engineering and Biotechnology
[2] Instituto de Pesquisa Pelé Pequeno Príncipe,Department of Chemistry, Centro Universitario de Ciencias Exactas e Ingenierías–CUCEI. C.P.44430
[3] Guadalajara University,undefined
来源
In Vitro Cellular & Developmental Biology - Animal | 2021年 / 57卷
关键词
Exopolysaccharide; Anti-tumor effect; Mitotane; Adrenocortical carcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
This study presents an in vitro evaluation of the antitumor potential of a chitin-like exopolysaccharide (EPS, produced by Mortierella alpina) on Adrenocortical carcinoma cells (ACC) compared to mitotane, a commercial drug commonly used in ACC treatment, and known for its side effects. Techniques of cellular viability determination such as MTT and fluorescence were used to measure the cytotoxic effects of the EPS and mitotane in tumoral cells (H295R) and non-tumoral cells (VERO), observing high cytotoxicity of mitotane and a 10% superior pro-apoptotic effect of the EPS compared to mitotane (p < 0.05). The cytotoxic effect of the EPS was similar to the effect of 50 μM mitotane on tumoral cells (p < 0.05). A decrement of the lysosomal volume was also noted in tumoral cells treated with the EPS. To enhance the antitumor effect, a combination of mitotane at a lower dosage and the EPS (as adjuvant) was also tested, showing a slight improvement of the cytotoxicity effect on tumoral cells. Therefore, the results indicate a cytotoxic effect of the EPS produced by Mortierella alpina on adrenocortical carcinoma, and a possible application in biomedical formulations or additional treatments.
引用
收藏
页码:395 / 403
页数:8
相关论文
共 286 条
  • [1] Allolio B(2006)Adrenocortical carcinoma: clinical update J Clin Endocrinol Metab 91 2027-2037
  • [2] Fassnacht M(2005)Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial Endocr Relat Cancer 12 657-666
  • [3] Berruti A(2004)Lifelong exposure to dietary fish oil alters macrophage responses in Walker 256 tumor-bearing rats Cell Immunol 231 56-62
  • [4] Terzolo M(1997)Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase J Biol Chem 272 26159-26165
  • [5] Sperone P(2012)Mechanisms of Action of (n-3) Fatty Acids, 2 J Nutr 142 592S-599S
  • [6] Pia A(2013)Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors J Clin Oncol 31 2619-2626
  • [7] Della Casa S(2001)Adrenal cortical carcinoma World J Surg 25 914-926
  • [8] Gross DJ(2014)Adrenocortical Carcinoma Endocr Rev 35 282-326
  • [9] Carnaghi C(2012)Combination chemotherapy in advanced adrenocortical carcinoma N Engl J Med 366 2189-2197
  • [10] Casali P(1996)Neoplasms of the adrenal cortex Cancer Med 1 1567-7